Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • BLOG
    • IPILOGUE EDITORS
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
  • INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • OTHER ACTIVITIES
    • IP WRITING CHALLENGE
    Home
    >
    Teva

    Tag: Teva

    December 12, 2019in Blogs, IP Intensive0by Editor
    771

    Not a Generic Law School Experience: My Internship at Teva Canada Limited

    If I had to distill my experience at Teva Canada Limited (“Teva”) down to a single word, it would be “exposure”. Throughout my 10-week internship for Osgoode’s Intellectual Property (IP)…

    Read more
    January 22, 2013in Canada, Feature Post, IP, IP Intensive, Patent Practice, Patents0by Editor
    891

    The Teva Experience: A Semester in Osgoode's IP Intensive Program

    As part of Osgoode’s Intellectual Property Law Intensive Program, I had the opportunity to spend ten weeks at Teva Canada working with in-house counsel. Teva Canada is one of Canada’s largest generic pharmaceutical…

    Read more
    November 9, 2012in Access to Medicines, Canada, Feature Post, IP, Patents, Pharmaceutical Drugs1by Editor
    269

    Canada’s Top Court Gives Canadians Something to Get Excited About, Generic Viagra!

    On November 8, 2012 the Supreme Court of Canada (SCC) released its eagerly anticipated decision in the “Viagra Appeal”. In a unanimous decision written by Justice LeBel, the SCC found…

    Read more
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736